Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2003
11/05/2003EP1357895A2 Vaccine composition and stabilisation method
11/05/2003EP1178960B1 Vitamin d analogues and their pharmaceutical use
11/05/2003EP1107973B1 NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY
11/05/2003EP1082298B1 1-alpha-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
11/05/2003EP1068194B1 Pde iv inhibiting pyridine derivatives
11/05/2003EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/05/2003EP1037670B1 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases
11/05/2003EP0989985B1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors
11/05/2003EP0902007B1 Chalcone derivatives and drugs containing the same
11/05/2003EP0863991B1 Antigenic preparations
11/05/2003EP0770064B1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
11/05/2003EP0699073B1 xenogeneic transplantation
11/05/2003EP0656061B1 Novel glycoforms of soluble complement receptor 1
11/05/2003EP0652874B1 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
11/05/2003EP0489837B1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction
11/05/2003CN1454254A Purging of cells using viruses
11/05/2003CN1454216A Antibodies to CCR5
11/05/2003CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
11/05/2003CN1454210A 嘧啶衍生物 Pyrimidine derivatives
11/05/2003CN1454204A IL-8 receptor antagonists
11/05/2003CN1454097A Polymer-modified synthetic proteins
11/05/2003CN1454091A Immunostimulatory nucleic acids
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/05/2003CN1453291A Synthesis and use of organic polypeptide compound
11/05/2003CN1452969A Medical preparation for parenteral administration
11/05/2003CN1126753C Pyrazolo (3,4-D) pyrimidines for anticonvulsive and antialiergic/antiasthmatic action
11/05/2003CN1126741C Substituted benzamides compound
11/05/2003CN1126568C Adjuvant used in vaccine
11/05/2003CN1126558C Medicine for treating kidney damage caused by immunological disease lupus erythematosus
11/05/2003CN1126552C Marine biological selenium products and preparing process thereof
11/05/2003CN1126535C Aqueous suspension for nasal administration of loteprednol
11/04/2003US6642367 Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom
11/04/2003US6642267 Side effect reduction over opioid analgesics; analgesic and/or anxiolytic action
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6642249 3-Oxo-pyrazolo(4,3-c) -quinolin-2-yl, -thiochroman-2-yl, or -chromen-2-yl derivatives; CD80 antagonists
11/04/2003US6642239 Dipeptide nitrile cathepsin K inhibitors
11/04/2003US6642237 Inhibitors of HIV protease and inhibitors of HIV replication, used in the prevention or treatment of infection by HIV and treatment for AIDS
11/04/2003US6642233 Strong affinity and high selectivity for the human NK1 receptors of substance P.
11/04/2003US6642232 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
11/04/2003US6642227 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
11/04/2003US6642226 Such as cis-(3,5-bis-trifluoromethyl-phenyl)-(4-(4-methyl-piperazin-1-yl),-3-phenyl -piperidin-1-yl)-methanone; for treatment of diseases related to neurokinin receptors
11/04/2003US6642225 Diazacycloalkanedione derivatives
11/04/2003US6642206 Monocyclic L-nucleosides, analogs and uses thereof
11/04/2003US6642008 Assays and therapies for latent viral infection
11/04/2003US6641846 Having anti-allergic effect, which can also be used as an immune regulator
11/04/2003US6641843 Pharmaceutical compositions
11/04/2003US6641836 Process for enhancing immune response in canines using a dietary composition including garlic
11/04/2003US6641817 Herpes virus vectors for dendritic cells
11/04/2003US6641816 Use of poxviruses as enhancer of specific immunity
11/04/2003US6641808 Composition for treatment of obesity
11/04/2003US6641611 A coating for an intravascular implant that prevents hyperproliferative vascular disease, includes repamyicin as first agent which acts on calcium independent cellular pathway and second agent is cyclosporin A
11/04/2003CA2188283C Substituted 1,3-oxathiolanes with antiviral properties
11/04/2003CA2040555C Cloned glutamic acid decarboxylase
10/2003
10/31/2003CA2444598A1 Compositions useful as inhibitors of gsk-3
10/30/2003WO2003089624A2 Fc receptor homolog, reagents, and uses thereof
10/30/2003WO2003089608A2 Drg11-responsive (dragon) gene family
10/30/2003WO2003089593A2 Adjuvant enhanced immunotherapy
10/30/2003WO2003089583A2 Tissue specific genes and gene clusters
10/30/2003WO2003089571A2 Ehrlichia canis genes and vaccines
10/30/2003WO2003089449A2 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity
10/30/2003WO2003089440A1 Polymorph of ascomycin derivative
10/30/2003WO2003089439A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof
10/30/2003WO2003089438A1 Labeled oxazinocarbazoles as diagnostic agents
10/30/2003WO2003089434A2 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF
10/30/2003WO2003089425A1 Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-$g(a), $g(a)-dimethyl-benzeneacetic
10/30/2003WO2003089416A1 Substituted pyrimidine-2,4(1h,3h)-diones for use as matrix metalloproteinase (mmp) inhibitors
10/30/2003WO2003089410A1 Phenylalanine derivative
10/30/2003WO2003089405A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition
10/30/2003WO2003089046A1 Method of treating biological materials with translating electrical fields and electrode polarity reversal
10/30/2003WO2003089010A1 Glycodendrimers having biological activity
10/30/2003WO2003089009A1 Microparticles comprising carbohydrate beads covalently linked with allergen
10/30/2003WO2003089004A1 Preventives for hiv infection
10/30/2003WO2003088988A1 Compositions for preventing or treating pollenosis, allergic nephritis, atopic dermatitits, asthma or urticaria
10/30/2003WO2003088979A2 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof
10/30/2003WO2003088977A1 (20S)-1α-HYDROXY-2α-METHYL AND 2β-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
10/30/2003WO2003088972A1 Novel compounds
10/30/2003WO2003088967A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/30/2003WO2003088945A1 Aerosol containing a particulate active substance
10/30/2003WO2003088908A2 Heterocyclo inhibitors of potassium channel function
10/30/2003WO2003088903A2 Compounds, compositions, and methods
10/30/2003WO2003088900A2 Solid forms of salts with tyrosine kinase activity
10/30/2003WO2003088748A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003WO2003066629A3 Heteroaryl compounds useful as inhibitors of gsk-3
10/30/2003WO2003055989A3 Cellular compositions and methods of making and using them
10/30/2003WO2003051388A3 Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
10/30/2003WO2003051277A3 Novel compounds
10/30/2003WO2003049783A3 Device and methods for harvesting tissue samples of known geometry
10/30/2003WO2003049680A3 Compositions containing both sedative and non-sedative antihistamines
10/30/2003WO2003048148A3 Statin-like compounds
10/30/2003WO2003034903A3 Psma antibodies and protein multimers
10/30/2003WO2003031568A3 Intracellular signaling molecules
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003024455A3 Stent coated with a sustained-release drug delivery and method for use thereof
10/30/2003WO2003024419B1 Apoptosis-mimicking natural vesicles and use thereof in medical treatment
10/30/2003WO2003020320A3 Nanoparticles comprising biologically active tnf which is immobilised on the same
10/30/2003WO2003018836A3 Model of autoimmune disease and methods for identifying agents against autoimmune disease
10/30/2003WO2003018619A3 Antimicrobial and anti-inflammatory peptides
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003004501A3 (hetero) aryl substituted benzofurans as 5-ht ligands
1 ... 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 ... 1172